SterileAtlas Marketplaces

DiscoveryAcademic Preclinical Labs Process Dev (PDO)CDMOs

ClinicalCROs Clinical Sites Ethics / IRB Central Labs

QualityPharmacovigilance Regulatory Engineering Consultants

SupplySuppliers Equipment Packaging

DistributionLogistics Distribution Specialty Pharmacy

AccessPayers PBM

CapitalInvestors IP & Legal

SterileAtlasIntelligence Mission Control

Loading…

SterileAtlas

One marketplace for the entire drug lifecycle — global sterile pharmaceutical & biotech manufacturing intelligence.

Marketplaces

All 22 marketplaces
CDMOs
CROs
Clinical trial sites
Consultants

Opportunities

Projects, jobs & leads
Open projects
Jobs
Consulting leads

Platform

Pricing
About us
List your company
Mission Control

© 2026 SterileAtlas · Capability scores are deterministic, rules-based — not AI.

About us Terms Usage Policy Disclosures Compliance Community guidelines Privacy Cookies Refunds DPA Trust & security

Data shown across the platform is illustrative and unverified — not for vendor qualification or regulatory use.

Clinical Development

Clinical Trial Sites

Sites, AMCs & investigator networks

4

sites listed

Identify, qualify and engage trial sites and investigator networks — ranked on trial readiness and recruitment.

SearchFaceted, over real records CompareSide-by-side scorecards Post an RFxGet qualified responses CollaborateRun it in a shared room AI assistantYour organisation, this market

Scores are deterministic, rules-based — not AI.

MarketplacesClinical Sites

4 sites

Sort

Trial readiness Recruitment strength Investigator depth Operational efficiency Digital maturity Compliance strength Patient volume Fastest startup Name (A–Z)

Therapeutic areas

Cardiology4 Cell & Gene Therapy4 Immunology4 Neurology4 Oncology4 Hematology3 Infectious Diseases3 Rare Diseases3 Endocrinology2 Respiratory2 Pediatrics1

Phases & studies

Phase I First-in-human Phase II Phase III Phase IV Device trials Observational RWE

Technology

Decentralized eConsent Remote monitoring eSource Telemedicine Wearables

Capabilities

Cell therapy Genomic Biobanking KOL on staff

Compliance

GCP compliant Verified Accepting studies Clean inspection

Accreditations

GCP12 CAP4 ISO 151894 ISO 90014 AAHRPP3 JCI3

Ownership structure

University6 Government4 Non-profit1 Public1

Patient diversity index

Any diversity index ≥ 55 diversity index ≥ 66 diversity index ≥ 72 diversity index ≥ 84 diversity index

Investigator count

Any investigator count ≥ 120 investigators ≥ 160 investigators ≥ 200 investigators

Active patient database

Any patient database ≥ 90k patients ≥ 120k patients ≥ 200k patients

Contract turnaround

Any contract turnaround ≤ 24 days ≤ 28 days ≤ 30 days ≤ 33 days

Country

Belgium China Germany Japan Sweden USA

Showing 4 of 4Clear filters University Remote monitoring

Charité

Charité – Universitätsmedizin Berlin

University Hospital · Berlin, Germany

90ready

Cell therapyGenomicBiobankingDCT

GCPPh I/II/III/IVOncologyHematologyImmunology

REC 0INV 00 PIs

AcceptingComprehensive site

JHM

Johns Hopkins Medicine

Academic Medical Center · Baltimore, MD, USA

90ready

Cell therapyGenomicBiobankingDCT

GCPPh I/II/III/IVOncologyHematologyImmunology

REC 0INV 00 PIs

AcceptingComprehensive site

UCSF

UCSF Medical Center

University Hospital · San Francisco, CA, USA

74ready

Cell therapyGenomicBiobankingDCT

GCPPh I/II/III/IVOncologyImmunologyNeurology

REC 0INV 00 PIs

AcceptingBroad capability

University Hospital Leuven (UZ Leuven)

University Hospital · Leuven, Belgium

74ready

Cell therapyGenomicBiobankingDCT

GCPPh I/II/III/IVOncologyHematologyImmunology

REC 0INV 00 PIs

AcceptingBroad capability